Skip to content
Search
Search for:
CTTI
Clinical Trials Transformation Initiative
Join Our Newsletter
Who We Are
Who We Are
Transforming Trials 2030
Join Transforming Trials 2030
Organizational Structure
Executive Committee
Mark B McClellan, MD, PhD
John Alexander, MD, MHS, FACC
M. Khair ElZarrad, PhD, MPH
Donna R. Cryer, JD
Pat Furlong
Steven K. Galson, MD, MPH
Patricia Hurley, MSC
Michael Kolodziej, MD
Theodore Lystig, PhD
Rod MacKenzie, PhD
Pierre Meulien, PhD
Robert Temple, MD
Spiros Vamvakas, MD
Bram Zuckerman, MD
Steering Committee
Staff
Membership
Benefits & Responsibilities
Annual Membership Dues
Become A Member
Become a Patient/Caregiver Rep
Meet Our Current Patient/Caregiver Reps
Annual Accomplishments
Funding
Transparency
Our Work
Our Work
All Recommendations & Resources
Quality
Quality By Design
Measuring Trials Transformation
Informing ICH E6 Renovation
Diversity
ClinicalTrials.gov Reporting Challenges
Recruitment
Pregnancy Testing
State of Clinical Trials
Clinical Trials Issues Related to COVID-19
Engaging All Stakeholders in Clinical Trial Design
Digital Health Trials
Developing Novel Endpoints
Planning Decentralized Trials
Selecting and Testing a Digital Health Technology
Managing Data
Supporting Sites
Interacting with Regulators
Novel Clinical Trial Designs
Real-World Data
Disease Progression Modeling
Master Protocol Studies
Trials in Clinical Practice
Antibacterial Drug Development
ABDD HABP/VABP Studies
ABDD Peds Trials
ABDD Streamlining HABP/VABP Trials
ABDD Unmet Need
Registry Trials
Electronic Healthcare Data
Large Simple Trials
Patient Engagement
Patient Group Engagement
Patient Engagement Collaborative
Investigators and Sites
Investigator Community
Investigator Qualification
Study Start-Up
Ethics and Human Research Protection
Single IRB
Informed Consent
Safety Reporting
Data Monitoring Committees
Newsroom
Newsroom
CTTI History
CTTI News
Publications
Webinars
Media Coverage
CTTI Meetings
Press Releases
Case Studies
CTTI Presentations
Contact us
Search
Expert Meetings
Search